CCCMHPIE

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Employees:
    1 - 24
Company types
Association/Government
Contact info
  • 11-12F, No. 3 bldg, Beijing INN, No. 6 Nanzhugan Hutong, Beijing, Doncheng, China
Meet us at

CPHI Americas 2026

Pennsylvania Convention Center, Philadelphia
2 Jun 2026 - 4 June 2026

CPHI South East Asia 2026

QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026

CPHI Korea 2026

COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

CPHI India 2026

IICC, Yashobhoomi, Dwarka, Delhi
23 Nov 2026 - 25 Nov 2026

Pharmapack Europe 2027

Paris Expo, Porte de Versailles - Hall 4 | Paris, France
27 Jan 2027 - 28 Jan 2027

Products from CCCMHPIE (37)

  • Amifostine for Injection

    Product Amifostine for Injection

    Chemotherapy: used prior to chemotherapy in patients with various cancers, including lung cancer, ovarian cancer, breast cancer, nasopharyngeal carcinoma, bone tumors, gastrointestinal tumors, and hematological malignancies, to significantly ease the toxic effects of chemotherapeutic agents on the kidneys,...
  • Cetrorelix Acetate for Injection

    Product Cetrorelix Acetate for Injection

    In assisted reproductive technology, this product is used in patients undergoing controlled ovarian stimulation to prevent premature ovulation.
  • Cyclovirobuxine D tablet

    Product Cyclovirobuxine D tablet

    Promotes circulation of qi and blood, unblocks the channels, and relieves pain. Indicated for chest impediment and cardiac pain caused by qi stagnation and blood stasis, with manifestations such as intermittent and knotted pulse; applicable to patients with coronary heart disease and arrhythmia presenting ...
  • Doxofylline Injection

    Product Doxofylline Injection

    Bronchial asthma, chronic asthmatic bronchitis, and dyspnea caused by other bronchospasms.
  • Vidarabine Monophosphate for Injection

    Product Vidarabine Monophosphate for Injection

    For the treatment of stomatitis, dermatitis, encephalitis caused by herpes virus infection, and cytomegalovirus infection.
  • Ketorolac Trometamol Injection

    Product Ketorolac Trometamol Injection

    This product is indicated for the short-term management of acute moderate to severe pain requiring opioid-level analgesia, typically for postoperative pain relief. It is not indicated for the treatment of mild pain or chronic pain.
  • Lornoxicam for Injection

    Product Lornoxicam for Injection

    Indicated for acute moderate postoperative pain, as well as pain associated with acute lumbar and sciatic neuralgia.
  • Peramivir Injection

    Product Peramivir Injection

    Indicated for the treatment of influenza type A or type B.
  • Phloroglucinol Injection

    Product Phloroglucinol Injection

    Indicated for acute spasmodic pain caused by dysfunction of the digestive system and biliary tract; acute spasmodic pain of the urethra, bladder, and renal colic, as well as gynecological spasmodic pain.
  • Tedizolid Phosphate for Injection

    Product Tedizolid Phosphate for Injection

    Indicated for the treatment of skin and skin structure infections, staphylococcal infections, and bacterial skin diseases.
  • 2'-Fluoro-2'-deoxycytidine

    Product 2'-Fluoro-2'-deoxycytidine

    2'-Deoxy-2'-fluorocytidine can synergize with T705 to enhance the antiviral efficacy of both compounds against CCHFV replication, and is widely used in the development of antiviral bioactive molecules and drug molecules. Firstly, it has garnered significant attention as an effective inhibitor of Crimean-Co...

CCCMHPIE Resources (2)